Oklahoma Administrative Code › Title 310 - Oklahoma State Department of Health › Chapter 638 - Drug and Alcohol Testing › Subchapter 1 - General Provisions › Section 310:638-1-8 - Urine specimen collection procedures

Current through Vol. 41, No. 20, July 1, 2024
(a)
Designation of collection
				site.
Each urine drug testing program shall have one or more designated
				collection sites which have all necessary personnel, materials, equipment,
				facilities, and supervision to provide for the collection, security, temporary
				storage, and shipping or transportation of urine specimens to a licensed drug
				testing facility.
(b)
Security.
Procedures shall provide for the designated collection
				site to be secure. If a collection site facility is dedicated solely to urine
				collection, it shall be secure at all times. If a facility cannot be dedicated
				solely to drug testing, the portion of the facility used for testing shall be
				secured during drug testing.
(c)
Chain of custody.
Chain of custody standardized forms shall be
				properly executed by authorized collection site personnel upon receipt of
				specimens. Handling and transportation of urine specimens from one authorized
				individual or place to another shall always be accomplished through chain of
				custody procedures. Every effort shall be made to minimize the number of
				persons handling specimens.
(d)
Access to authorized personnel only.
No unauthorized personnel
				shall be permitted in any part of the designated collection site when urine
				specimens are collected or stored.
(e)
Privacy.
Procedures for
				collecting urine specimens shall allow individual privacy. No employer or
				representative, agent or designee of the employer shall directly observe an
				applicant or employee in the process of producing a urine sample, provided
				collection occurs in a manner reasonably calculated to prevent substitutions or
				interference with the collection or testing of reliable samples.
(f)
Integrity and identity of
				specimen.
Precautions shall be taken to ensure that a urine specimen is
				not adulterated or diluted during the collection procedure and that information
				on the urine specimen bottle and on the chain of custody form can identify the
				individual from whom the specimen was collected. The following minimum
				precautions shall be taken to ensure that unadulterated specimens are obtained
				and correctly identified:
(1) To deter the
				dilution of specimens at the collection site, toilet bluing agents shall be
				placed in toilet tanks wherever possible, so the reservoir of water in the
				toilet bowl always remains blue. There shall be no other source of water i.e.,
				no shower or sink, in the enclosure where urination occurs.
(2) When an individual arrives at the
				collection site, the collection site person shall request the individual to
				present photo identification. If the individual does not have proper photo
				identification, the collection site person shall contact the supervisor of the
				individual, the coordinator of the drug testing program, or any other employer
				official who can positively identify the individual. If the individual's
				identity cannot be established, the collection site person shall not proceed
				with the collection.
(3) If the
				individual fails to arrive at the assigned time, the collection site person
				shall contact the appropriate authority to obtain guidance on the action to be
				taken.
(4) The collection site
				person shall ask the individual to remove any unnecessary outer garments such
				as a coat or jacket that might conceal items or substances that could be used
				to tamper with or adulterate the individual's urine specimen. The collection
				site person shall ensure that all personal belongings such as a purse or
				briefcase remain with the outer garments. The individual may retain his or her
				wallet.
(5) The individual shall be
				instructed to wash and dry his or her hands prior to urination.
(6) After washing hands, the individual shall
				remain in the presence of the collection site person and shall not have access
				to any water fountain, faucet, soap dispenser, cleaning agent or any other
				materials which may be used to adulterate the specimen.
(7) The individual may provide the specimen
				in the privacy of a stall or otherwise partitioned area that allows for
				individual privacy.
(8) The
				collection site person shall note any unusual behavior or appearance on the
				chain of custody form.
(9) In the
				exceptional event that a drug testing program designated collection site is not
				accessible and there is an immediate requirement for specimen collection (e.g.,
				an accident investigation), a public rest room may be used according to the
				following procedures: A collection site person of the same gender as the
				individual shall accompany the individual into the public rest room which shall
				be made secure during the collection procedure. If possible, a toilet bluing
				agent shall be placed in the bowl and any accessible toilet tank. The
				collection site person shall remain in the rest room, but outside the stall,
				until the specimen is collected. If no bluing agent is available to deter
				specimen dilution, the collection site person shall instruct the individual not
				to flush the toilet until the specimen is delivered to the collection site
				person. After the collection site person has possession of the specimen, the
				individual shall be instructed to flush the toilet and to participate with the
				collection site person in completing the chain of custody procedures.
(10) Upon receiving the specimen from the
				individual, the collection site person shall determine that it contains at
				least forty-five (45) ml of urine under the split sample method of collection
				or thirty (30) ml of urine under the single sample method of collection.
(A) If drug testing is to be conducted in a
				testing facility which performs both the initial screening test and the
				confirmatory test at the same location, urine may be collected under either the
				single sample method of collection, or the split sample method of
				collection.
(B) If drug testing is
				to be conducted in a testing facility which performs only the initial screening
				test, the split sample method of collection shall be used.
(i)
Split sample collection
				method.
(I) The donor shall urinate
				into a container or a specimen bottle capable of holding at least sixty (60)
				ml.
(II) If a collection container
				is used, the collection site person, in the presence of the donor, pours the
				urine into two specimen bottles. Thirty (30) ml shall be poured into one
				bottle, to be used as the primary specimen. At least fifteen (15) ml shall be
				poured into the other bottle, to be used as the split specimen.
(III) If a single specimen bottle is used as
				a collection container, the collection site person shall pour thirty (30) ml of
				urine from the specimen bottle into a second specimen bottle to be used as the
				primary specimen and retain the remainder, i.e., at least fifteen (15) ml, in
				the collection bottle to be used as the split specimen.
(IV) Both bottles shall be shipped in a
				single shipping container to the testing facility.
(ii)
Single sample collection
				method.
(I) The collection site person
				may choose to direct the donor to urinate either directly into a specimen
				bottle or into a separate collection container.
(II) If a separate collection container is
				used, the collection site person shall pour at least thirty (30) ml of the
				urine from the collection container into the specimen bottle in the presence of
				the donor.
(C) In either collection methodology, upon
				receiving the specimen from the donor, the collection site person shall
				determine if it has at least thirty (30) ml of urine for the primary or single
				specimen bottle, and where the split specimen collection method is used, an
				additional fifteen (15) ml of urine for the split specimen bottle. If the
				individual is unable to provide such a quantity of urine, the collection site
				person shall instruct the individual to drink not more than twenty-four (24)
				ounces of fluids and, after a period of up to two (2) hours, again attempt to
				provide a complete sample using a fresh collection container. The original
				insufficient specimen shall be discarded. If the donor is still unable to
				provide an adequate specimen, the insufficient specimen shall be discarded,
				testing discontinued, and an official of the drug testing program so
				notified.
(11) After the
				specimen has been provided and submitted to the collection site person, the
				individual shall be allowed to wash his or her hands.
(12) Immediately after the specimen is
				collected, the collection site person shall measure the temperature of the
				specimen. The temperature measuring device used shall accurately reflect the
				temperature of the specimen and not contaminate the specimen. The time from
				urination to temperature measurement is critical and in no case shall exceed
				four (4) minutes.
(13) If the
				temperature of a specimen is outside the range of 32 -
				37oC/90 - 100oF, that is
				a reason to believe that the individual did alter or substitute the specimen,
				and another specimen shall be collected under direct observation of a same
				gender collection site person and both specimens shall be forwarded to the
				testing facility for testing. An individual may volunteer to have an oral
				temperature taken to provide evidence to counter the reason to believe the
				individual did alter or substitute the specimen caused by the specimen's
				temperature falling outside the prescribed range.
(14) Immediately after the specimen is
				collected, the collection site person shall also inspect the specimen to
				determine its color and look for any signs of contaminants such as unusual odor
				or sudsing. Any unusual findings shall be noted on the chain of custody
				form.
(15) All specimens suspected
				of being adulterated shall be forwarded to the testing facility for
				testing.
(16) Whenever there is
				reason to believe that a particular individual did alter or substitute the
				specimen provided, a second specimen shall be obtained as soon as possible
				under the direct observation of a same gender collection site person.
(17) Both the individual being tested and the
				collection site person shall keep the specimen in view at all times prior to
				its being sealed and labeled. If the specimen is transferred to a second
				bottle, the collection site person shall request the individual to observe the
				transfer of the specimen and the placement of the tamper-proof seal over the
				bottle cap and down the sides of the bottle.
(18) The collection site person and the
				individual shall be present at the same time during procedures outlined in
				paragraphs (f)(19) - (f)(22) of this section.
(19) The collection site person shall place
				securely on the bottle an identification label which contains the date, the
				individual's specimen number, and any other identifying information provided or
				required by the drug testing program.
(20) The individual shall initial the
				identification label on the specimen bottle for the purpose of certifying that
				it is the specimen collected from the individual.
(21) The collection site person shall
				indicate on the chain of custody form all information identifying the specimen.
				The collection site person shall sign the chain of custody form next to the
				identifying information.
(22) The
				individual shall be asked to read and sign a statement certifying that the
				specimen identified as having been collected from the individual is in fact
				that specimen the individual provided.
(23) A higher level supervisor shall review
				and concur in advance with any decision by a collection site person to obtain a
				specimen under the direct observation of a same gender collection site person
				based on a reason to believe that the individual did alter or substitute the
				specimen provided.
(24) The
				collection site person shall complete the chain of custody form.